The life sciences industry is bursting with innovation. Novel therapies, technologies, and delivery models are emerging constantly, promising better patient outcomes and new commercial opportunities.
What often limits their impact is not the quality of the science, but the ability to move discoveries methodically into the clinic. Companies frequently face challenges navigating regulatory pathways, designing efficient trials, securing funding, and building the operational infrastructure needed to scale safely and effectively.
This session tackles these challenges head-on, spotlighting Maryland-based startups with national impact that have successfully advanced innovations into clinical trials. Through data-driven strategies, partnerships, and practical lessons—including applications of AI and analytics—attendees will gain actionable insights to accelerate clinical programs, mitigate risk, and build sustainable impact.
Participants will leave with guidance on:
Aligning cross-sector resources and teams for clinical execution
Building operational infrastructure that supports safe and scalable growth
Understanding regulatory, quality, and manufacturing considerations critical to success
By emphasizing both opportunity and operational reality, this session highlights Maryland as a hub for clinically-ready, ecosystem-aligned life sciences innovation.
